Upgrade to SI Premium - Free Trial

BioMarin Pharma (BMRN) Tops Q3 Revenue

October 23, 2019 4:16 PM
BioMarin Pharma (NASDAQ: BMRN) reported Q3 EPS of $0.30, which may not compare to the analyst estimate of $0.06. Revenue ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance

Next Articles